Zealand Pharma A/S (ZLDPF)
Develops injectable medicines treating severe low blood sugar and digestive disorders.
$45.50+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-11.8%
The outlook
ZLDPF is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Analyst coverage appears thin, and the stock's bearish positioning suggests limited near-term momentum. The unusually low P/E reflects the company's unprofitable status typical of early-stage pharma firms.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range20% of the way from its 52-week low to high
Market cap
$3.12B
52-wk high
$83.12
52-wk low
$35.93
50-day avg
$45.79
200-day avg
$57.97
Trailing P/E
3.3